SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company's total revenue for the quarter ended June 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 44980.70 millions.The Company to register a -37.52%  fall in the net profit for the quarter ended June 2024.The company reported a degrowth in operating Profit to 8438.10 millions from 11123.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 44980.70 44660.70 0.72 44980.70 44660.70 0.72 202751.70 208121.40 -2.58
Other Income 827.40 1635.40 -49.41 827.40 1635.40 -49.41 5534.80 3292.90 68.08
PBIDT 8438.10 11123.00 -24.14 8438.10 11123.00 -24.14 60533.70 67518.90 -10.35
Interest 2160.80 1579.40 36.81 2160.80 1579.40 36.81 7840.80 4721.80 66.06
PBDT 6277.30 8051.50 -22.04 6277.30 8051.50 -22.04 50502.70 33419.20 51.12
Depreciation 3698.10 4152.70 -10.95 3698.10 4152.70 -10.95 16006.20 16008.70 -0.02
PBT 2579.20 3898.80 -33.85 2579.20 3898.80 -33.85 34496.50 17410.50 98.14
TAX 201.00 92.40 117.53 201.00 92.40 117.53 5914.70 503.30 1075.18
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2378.20 3806.40 -37.52 2378.20 3806.40 -37.52 28581.80 16907.20 69.05
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 18.76 24.91 -24.68 18.76 24.91 -24.68 29.86 32.44 -7.97

Sun Pharma Inds. Share Price

1872.40 25.10 (1.36%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×